Cointime

Feel Therapeutics

company

About

Feel Therapeutics develops Biomarkers and Digital Therapeutics to change the way we diagnose, manage, and care for mental health.

  • 11 - 50

Highlights

Total Funding Amount
$10.50M
Funding Rounds
3
Investors
4

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$4.20M
Industries
Biotechnology,Health Care,Health Diagnostics,Health Insurance,Medical Device,Psychology
Founded date
Jul 20, 2015
Number Of Employee
11 - 50
Operating Status
Active

Feel Therapeutics is developing Digital Biomarkers and Therapeutics to bring objective data and measurement in how we diagnose, manage and care for Mental Health.

The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and partners with large Pharmaceuticals to develop novel digital biomarkers and bring digital health solutions to market as standalone programs (DTx) or alongside medications (Rx+).

Find out more about Feel at www.feeltherapeutics.com or contact us at [email protected]

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$10.50M
Feel Therapeutics has raised a total of $10.50M in funding over 2 rounds. Their latest funding was raised on Aug 6, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 6, 2020 Series Unknown $4.20M 2 — — Detail
Jan 10, 2019 Seed $4.50M 1 — — Detail
Dec 20, 2017 Pre-seed $1.80M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
4
Feel Therapeutics is funded by 4 investors. Sapien Ventures and Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Sapien Ventures — Series Unknown
Gaingels — Series Unknown
HAX — Seed
Make in LA — Pre-seed
Cointime
เนื้อหา
บริษัท